Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2018-04-12 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2017年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2017年度内部控制自我评价报告' which translates to '2017 Annual Internal Control Self-Evaluation Report'. It is a detailed report on the company's internal control environment, risk assessment, control activities, communication, and supervision related to financial reporting and operational controls. The document includes a self-assessment of the effectiveness of internal controls over financial reporting as of December 31, 2017. It is not an announcement or a brief summary but a substantive report containing detailed internal control information. This type of document aligns with an Audit Report / Information (AR) category, which includes internal control reports and audit-related disclosures separate from the full Annual Report (10-K). The document is about internal control self-evaluation, which is a typical audit-related disclosure rather than a full annual report or other categories like management reports or regulatory filings. Therefore, the best classification is AR with high confidence. FY 2017
2018-04-12 Chinese
独立董事关于2017年度内部控制自我评价报告的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent director's opinion on the company's 2017 internal control self-evaluation report. It references regulatory frameworks related to internal control and governance but does not contain the full internal control report itself. The document is relatively short (782 characters) and serves as an opinion or certification rather than a full report. This fits the category of an Audit Report / Information (AR), which includes audit reports and internal control evaluations by independent directors, rather than a full Annual Report or Interim Report. Therefore, the classification is AR with high confidence. FY 2017
2018-04-12 Chinese
2018年度第一季度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a "2018年度第一季度业绩预告" which translates to "2018 First Quarter Earnings Forecast." It provides estimated financial performance for the period January 1 to March 31, 2018, including expected net profit and earnings per share. It explicitly states that the results are unaudited and that detailed financial data will be disclosed in the forthcoming first quarter report. The document is relatively short (1304 characters) and serves as a preliminary earnings forecast rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. Q1 2018
2018-04-12 Chinese
2017年年度报告（更新后）
Annual Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司 2017 年年度报告全文" which translates to "Chengdu Berry Genomics Co., Ltd. 2017 Annual Report Full Text." It contains detailed sections including company overview, financial data, business summary, governance, and financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes detailed financial figures, management discussion, and analysis, consistent with a full annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2017
2018-04-12 Chinese
关于2017年年度报告的更正公告
Regulatory Filings Classification · 95% confidence The document is titled as a correction announcement regarding the 2017 Annual Report of the company. It specifically states it is a "更正公告" (correction announcement) about the 2017 Annual Report, correcting certain financial statement notes related to non-operating income. The document is relatively short (2910 characters) and does not contain the full annual report or comprehensive financial statements, but rather a correction to a previously published annual report. It also includes an apology and explanation for the correction. According to the "MENU VS MEAL" rule, this is an announcement about a report correction, not the full report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous announcements and corrections that do not constitute the full report.
2018-04-12 Chinese
监事会对公司2017年度内部控制自我评价的意见
Audit Report / Information Classification · 95% confidence The document is a supervisory board opinion on the company's 2017 internal control self-evaluation report. It references regulatory guidelines on internal control and discusses the company's internal control system and its evaluation. The document does not contain full financial statements or detailed financial performance data, nor is it an announcement of a report publication. It is a standalone audit-related opinion on internal controls, which fits the category of Audit Report / Information (AR). The document length is short but contains substantive content related to internal control evaluation, not just a notice or certification. Therefore, the best classification is AR with high confidence. FY 2017
2018-04-12 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.